Biotechnology startups are capitalizing on precision medicine to uncover new drug targets, discover innovative drugs, provide gene therapies, and devise new drug delivery technologies.
Biotechnology startups are capitalizing on precision medicine to uncover new drug targets, discover innovative drugs, provide gene therapies, and devise new drug delivery technologies. In the field of oncology, precision medicine enables tailored cancer treatments based on individual genetic mutations. This trend is also making waves in rare disease research, where unique genetic insights are leading to groundbreaking therapies.